Announced Tue, 28 Apr · 17:25 IST

Solara Active Pharma Sciences Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Ownership Changes View source PDF

SOLARA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.2%1-day move
₹481.90
prior close
₹495.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.9+0.0-0.1-0.8+4.2+7.5+4.2+5.8+6.7+9.8+16.9+10.1+18.9
Up moveDown movePending
AI summary

Pronomz Ventures LLP, on behalf of the promoters and promoter group of Solara Active Pharma Sciences Limited, has submitted a declaration under SEBI Regulation 31(4) of the Takeover Regulations. The filing confirms that the promoters and promoter group have not created any new encumbrances (pledges) on their shares, other than those already disclosed during the financial year 2025-26. The disclosure covers 24 entities including individual promoters, LLPs, private companies, and trusts listed in Annexure A. This is a routine negative declaration filed to satisfy regulatory requirements for transparency on promoter share pledges.

Likely market impact

No immediate impact on the stock. The filing provides transparency that promoters have not increased their pledge obligations, which is a neutral-to-positive signal for investors concerned about potential pledge-related risks.